Suggestions
James Winokur
Chief Executive Officer, CitraChem; Board Member, Association of Cannabinoid Specialists (ACS)
James Winokur is an accomplished business executive and entrepreneur currently serving as the Chief Executive Officer of CitraChem Corp., a start-up life sciences company.12 CitraChem Corp. focuses on developing a patent-pending chemical synthesis process to create ultra-pure, cost-effective, single-molecule phytocannabinoids in a controlled laboratory environment.1
Professional Background
James has extensive experience in the cannabis industry:
- Founder of High Power Consulting, specializing in start-ups and small businesses, particularly in the cannabis sector1
- CEO of Berkshire Roots, a Massachusetts-based cannabis cultivation, production, and dispensary operator (December 2019 - April 2023)2
- SVP & General Manager, Product Group at MariMed Inc., a multi-state cannabis operator (December 2018 - November 2019)2
- Co-founder and CEO of CannaKorp, a company that developed a pod-based cannabis vaporizer home appliance (May 2014 - March 2019)2
Earlier Career
Before entering the cannabis industry, James held significant positions in other sectors:
- Senior Director of Marketing & Business Development for Global Support at PTC, contributing to sustaining $650 million in annual revenue2
- General Manager at Bedworks Inc., a furniture manufacturing and retail company2
- VP & General Manager at Culligan International, dealing with water treatment products and services2
Education
James holds the following degrees:
- MBA in Marketing and Operations from Boston College Carroll School of Management (2000-2002)2
- B.A. in Political Science from Boston College (1982-1986)2
Additional Roles
In addition to his primary role at CitraChem Corp., James serves on the Board of Directors for the Association of Cannabinoid Specialists (ACS), an international association of healthcare professionals focused on cannabinoid medicine.2 He contributes his expertise in business development, marketing, and operations to support ACS's mission of advancing cannabis medicine and patient care.